跳至主要内容
临床试验/NCT01847352
NCT01847352已完成不适用

Effect of Endogenous Iron Status on Hypoxic Pulmonary Vascular Responses and Their Attenuation by Intravenous Iron

University of Oxford1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2013年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
1
主要终点
∆PASP in iron-replete compared to iron-deficient volunteers

研究概览

简要总结

On exposure to hypoxia (low oxygen) the normal response is for pulmonary arterial systolic blood pressure (PASP, blood pressure through the lungs) to increase. We have previously shown that raising iron by giving an infusion of iron into a vein reduces this pressure rise and that lowering iron by giving a drug that binds iron, magnifies this response. This is potentially a clinically important observation since iron-deficient people may be at increased risk of pulmonary hypertension if exposed transiently or permanently to hypoxia due to lung disease or residence at high altitude; furthermore if this were true then intravenous iron could be an important treatment in this patient group in the event of hypoxic exposure. The observed effects of iron on PASP are likely to be because iron levels affect oxygen sensing. Low iron levels make the body behave as if exposed to low oxygen by inhibiting the breakdown of the family of oxygen-sensing transcription factors, 'hypoxia inducible factor' or HIF. This includes one of the body's normal responses to low oxygen levels - raising blood pressure through the lungs.

This study will answer the question (1) do iron-deficient volunteers have a greater rise in PASP with hypoxia than those who are iron-replete, and (2) does giving intravenous iron cause a greater reduction in the rise in PASP in those who are iron-deficient than iron-replete? The purpose of this study is not to test the safety or clinical efficacy of iron which is already known.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing and able to give informed consent for participation in the study
  • Men and women aged 18 years or older and generally in good health
  • Detectable tricuspid regurgitation on echocardiography during both normoxia and hypoxia enabling measurement of pulmonary arterial pressure
  • For iron-deficient volunteers: ferritin ≤15microg/L and transferrin saturation <16%
  • For iron-replete volunteers: ferritin ≥20microg/L and transferrin saturation ≥20%

排除标准

  • Haemoglobin <8.0g/dl
  • Haemoglobinopathy
  • Iron overload defined as ferritin >300microg/L
  • Hypoxia at rest or on walking (SaO2 <94%) or significant comorbidity that may affect haematinics, pulmonary vascular or ventilatory responses, e.g. current infection, a chronic inflammatory condition, known cardiovalvular lesion or pulmonary hypertension, uncontrolled asthma or chronic obstructive pulmonary disease
  • Exposure to high altitude (>2,500m) within the previous six weeks or air travel >4 hours within the previous week
  • Iron supplementation or blood transfusion within the previous 6 weeks
  • Pregnancy or breast feeding

研究组 & 干预措施

Iron-deficient

Other

Healthy volunteers meeting iron-deficient entry criteria; Intravenous administration of ferric carboxymaltose; Subacute hypoxic exposures

干预措施: Intravenous administration of ferric carboxymaltose (Drug)

Iron-deficient

Other

Healthy volunteers meeting iron-deficient entry criteria; Intravenous administration of ferric carboxymaltose; Subacute hypoxic exposures

干预措施: Subacute hypoxic exposures (Other)

Iron-replete

Other

Healthy volunteers meeting iron-replete entry criteria; Intravenous administration of ferric carboxymaltose; Subacute hypoxic exposures

干预措施: Intravenous administration of ferric carboxymaltose (Drug)

Iron-replete

Other

Healthy volunteers meeting iron-replete entry criteria; Intravenous administration of ferric carboxymaltose; Subacute hypoxic exposures

干预措施: Subacute hypoxic exposures (Other)

结局指标

主要结局

∆PASP in iron-replete compared to iron-deficient volunteers

时间窗: During six hours of hypoxia without prior iron infusion

Difference between the rise in pulmonary artery systolic pressure during a hypoxic challenge in iron-replete compared to iron-deficient volunteers

次要结局

  • ∆PASP, with versus without prior iron infusion, in iron-replete compared to iron-deficient volunteers(During two six-hour periods of hypoxia; assessments separated by at least a week)
  • Ventilation parameter changes, pre- versus post-intravenous iron, in iron-replete compared to iron-deficient volunteers(During six hours of hypoxia, at both study assessments)
  • Blood parameter changes, pre- versus post-intravenous iron, in iron-replete compared to iron-deficient volunteers(After six hours of hypoxia, at both study assessments)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验